Back to Top
Go Back
Journal Photo for Statistics in Biopharmaceutical Research
Peer reviewed only Open Access

Statistics in Biopharmaceutical Research (SBR)

Publisher : Taylor & Francis
industries; academic biostatisticians from schools of medicine veterinary medicine public health
e-ISSN 1946-6315
Issue Frequency Quarterly
Impact Factor 1.5
Est. Year 2009
Mobile 4402080520500
DOI YES
Language English
APC YES
Impact Factor Assignee GOOGLE SCHOLAR
Email enquiries@taylorandfrancis.com

Journal Descriptions

Statistics in Biopharmaceutical Research ( SBR), publishes articles that focus on the needs of researchers and applied statisticians in biopharmaceutical industries; academic biostatisticians from schools of medicine, veterinary medicine, public health, and pharmacy; statisticians and quantitative analysts working in regulatory agencies (e.g., U.S. Food and Drug Administration and its counterpart in other countries); statisticians with an interest in adopting methodology presented in this journal to their own fields; and nonstatisticians with an interest in applying statistical methods to biopharmaceutical problems. Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of statistics in all phases of research, development, and practice in the pharmaceutical, biopharmaceutical, device, and diagnostics industries. Articles should focus on the development of novel statistical methods, novel applications of current methods, or the innovative application of statistical principles that can be used by statistical practitioners in these disciplines. Areas of application may include statistical methods for drug discovery, including papers that address issues of multiplicity, sequential trials, adaptive designs, etc.; preclinical and clinical studies; genomics and proteomics; bioassay; biomarkers and surrogate markers; models and analyses of drug history, including pharmacoeconomics, product life cycle, detection of adverse events in clinical studies, and postmarketing risk assessment; regulatory guidelines, including issues of standardization of terminology (e.g., CDISC), tolerance and specification limits related to pharmaceutical practice, and novel methods of drug approval; and detection of adverse events in clinical and toxicological studies. Tutorial articles also are welcome.

Statistics in Biopharmaceutical Research (SBR) is :-

  • International, Peer-Reviewed, Open Access, Refereed, industries; academic biostatisticians from schools of medicine, veterinary medicine, public health , Online , Quarterly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1946-6315, Established: 2009, Impact Factor: 1.5
  • Provides Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing